Pneumonia News and Research

Latest Pneumonia News and Research

TreatFOOD research project develops food supplements to relieve malnutrition

Thirty-three million children worldwide suffer from moderate acute malnutrition. It affects human development and generally, increases susceptibility to illness. Unfortunately, the nutritional supplements and aid that these children may receive today is based upon dated standards developed for adults or otherwise intended for children with severe acute nutrition.

13 Sep 2013

Inhaled corticosteroids increase pneumonia risk in asthma

Research from the UK indicates that the use of inhaled corticosteroids is independently associated with an increased risk for pneumonia and lower respiratory tract infection in patients with asthma.

12 Sep 2013

CPT-F antibiotic drug may hold promise for treating potentially fatal MRSA pneumonia

A drug approved just two years ago for treating bacterial infections may hold promise for treating the potentially fatal MRSA pneumonia, according to a Henry Ford Hospital study.

12 Sep 2013

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

10 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

New prescribing protocol could reduce potential misuse of antibiotics

Researchers have developed a new strategy for prescribing antibiotics that could reduce patient harm and help combat the rise in antibiotic resistance.

10 Sep 2013

Findings could lead to improvements in pneumonia care, outcomes for patients

An electronic decision support tool helped to reduce deaths from pneumonia in four hospital emergency departments in a new study.

10 Sep 2013

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

National Institutes of Health (NIH) scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

10 Sep 2013

Emerging H7N9 virus has potential to cause a pandemic

A new study has found that a novel avian-origin H7N9 influenza A virus, which has recently emerged in humans, attaches moderately or abundantly to the epithelium of both the upper and lower respiratory tracts.

10 Sep 2013

Simple changes in family's lifestyle helps 12-year-old to fight diabetes

Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

Human Urine Metabolome Study Envisions New Diagnostic Era

...

6 Sep 2013

Incidence of septicemia increasing among service members, study finds

The annual incidence rates of primary diagnosed septicemia among active component service members increased nearly 580 percent from 2004 to 2012, according to a new study.

6 Sep 2013

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Researchers at the University of Alberta announced today that they have determined the chemical composition of human urine. The study, which took more than seven years and involved a team of nearly 20 researchers, has revealed that more than 3,000 chemicals or "metabolites" can be detected in urine.

6 Sep 2013

Indicators of poor preoperative health predict risk of major medical complications

For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

4 Sep 2013

Study estimates total annual costs for five major health care-associated infections

A study estimates that total annual costs for five major health care-associated infections (HAIs) were $9.8 billion, with surgical site infections contributing the most to overall costs, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

3 Sep 2013

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis led by St. Jude Children's Research Hospital. The report appears today in the advance online edition of the journal Pediatrics.

2 Sep 2013

Okana acquires North American product rights for FACTIVE tablets from Merus Labs International

Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.

31 Aug 2013

Five things every person should know about Parkinson's disease

Michael J. Fox is back in the spotlight this fall in a new sitcom "The Michael J. Fox Show" and spreading awareness about Parkinson's disease, a condition both he and his TV character have in common. Fox has been an outspoken advocate for Parkinson's disease research and awareness since disclosing his condition to the public in 1998.

30 Aug 2013

Pneumonia News and Research

Latest Pneumonia News and Research

TreatFOOD research project develops food supplements to relieve malnutrition

Inhaled corticosteroids increase pneumonia risk in asthma

CPT-F antibiotic drug may hold promise for treating potentially fatal MRSA pneumonia

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

New prescribing protocol could reduce potential misuse of antibiotics

Findings could lead to improvements in pneumonia care, outcomes for patients

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

Emerging H7N9 virus has potential to cause a pandemic

Simple changes in family's lifestyle helps 12-year-old to fight diabetes

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

Research roundup: The financial burden of hospital acquired infections

Human Urine Metabolome Study Envisions New Diagnostic Era

Incidence of septicemia increasing among service members, study finds

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Indicators of poor preoperative health predict risk of major medical complications

Study estimates total annual costs for five major health care-associated infections

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

Okana acquires North American product rights for FACTIVE tablets from Merus Labs International

Five things every person should know about Parkinson's disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pneumonia News and Research

Latest Pneumonia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in